WallStSmart

Lineage, Inc. Common Stock (LINE)vsStrawberry Fields REIT LLC (STRW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 3300% more annual revenue ($5.36B vs $157.65M). STRW leads profitability with a 5.3% profit margin vs -2.7%. STRW earns a higher WallStSmart Score of 56/100 (C).

LINE

Hold

36

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 3.0
Piotroski: 2/9Altman Z: 0.67

STRW

Buy

56

out of 100

Grade: C

Growth: 8.0Profit: 7.5Value: 5.0Quality: 2.5
Piotroski: 3/9Altman Z: 0.66
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LINE.

STRWOvervalued (-8.8%)

Margin of Safety

-8.8%

Fair Value

$11.76

Current Price

$13.82

$2.06 premium

UndervaluedFair: $11.76Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

STRW3 strengths · Avg: 9.3/10
Return on EquityProfitability
185.3%10/10

Every $100 of equity generates 185 in profit

Operating MarginProfitability
55.4%10/10

Strong operational efficiency at 55.4%

EPS GrowthGrowth
31.6%8/10

Earnings expanding 31.6% YoY

Areas to Watch

LINE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

Debt/EquityHealth
1.013/10

Elevated debt levels

STRW4 concerns · Avg: 3.3/10
Price/BookValuation
15.2x4/10

Trading at 15.2x book value

Market CapQuality
$190.25M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
5.3%3/10

5.3% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : STRW

The strongest argument for STRW centers on Return on Equity, Operating Margin, EPS Growth.

Bear Case : LINE

The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.

Bear Case : STRW

The primary concerns for STRW are Price/Book, Market Cap, Profit Margin. Debt-to-equity of 64.51 is elevated, increasing financial risk.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while STRW is a value play — different risk/reward profiles.

LINE carries more volatility with a beta of 0.91 — expect wider price swings.

STRW is growing revenue faster at 7.1% — sustainability is the question.

LINE generates stronger free cash flow (131M), providing more financial flexibility.

Bottom Line

STRW scores higher overall (56/100 vs 36/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.

Visit Website →

Strawberry Fields REIT LLC

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Strawberry Fields REIT, Inc., a self-managed and self-administered real estate investment trust, engages in the acquisition, ownership, and leasing of skilled nursing facilities and other post-acute healthcare properties. The company is headquartered in South Bend, Indiana.

Want to dig deeper into these stocks?